A COST-EFFECTIVENESS ANALYSIS OF THE CNICPOLYPILL STRATEGY, COMPARED TO USUAL CARE, IN SECONDARY CARDIOVASCULAR PREVENTION FROM A SPANISH PERSPECTIVE USING DATA FROM THE SECURE TRIAL

被引：0

作者：

Hopmans, M. ^{[1
]}

Castellano Vazquez, J. M. ^{[2
]}

Gaziano, T. ^{[3
]}

Dymond, A. ^{[4
]}

Looby, A. ^{[4
]}

Mealing, S. ^{[4
]}

Hansell, N. ^{[4
]}

Eastwood, I

Montpart, F. ^{[1
]}

Owen, R. ^{[5
]}

Pocock, S. ^{[5
]}

Cordero, A. ^{[6
,7
]}

Gonzalez-Juanatey, J. R. ^{[8
]}

Fernandez, A. ^{[9
]}

Merkely, B. ^{[10
]}

Linhart, A. ^{[11
]}

Schiele, F. ^{[12
]}

Doehner, W. ^{[13
]}

Roncaglioni, M. C. ^{[14
]}

Ponikowski, P. ^{[15
]}

Fuster, V ^{[2
]}

机构：

[1] Ferrer Int, Barcelona, Spain

[2] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain

[3] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[4] York Hlth Econ Consortium, York, N Yorkshire, England

[5] London Sch Hyg & Trop Med London, London, England

[6] Hosp Univ San Juan, Alicante, Spain

[7] Hosp Univ San Juan, Alicante, Spain

[8] Hosp Clin Univ Santiago De Compostela, Santiago De Compostela, Spain

[9] Hosp Univ Clin San Carlos, Madrid, Spain

[10] Varosmajori Sziv Ergyogyaszati Klin, Budapest, Hungary

[11] Vseobecna Fak Nemocn & Praze, Prague, Czech Republic

[12] Reg Univ Hosp Jean Minjoz, Besancon, France

[13] Charite Univ Med Berlin, Berlin, Germany

[14] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy

[15] Wroclaw Med Univ, Wroclaw, Poland

来源：

VALUE IN HEALTH | 2023年 / 26卷 / 12期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

EE615

引用

下载

页码：S171 / S171

页数：1

共 50 条

[1] Clinical and cost-effectiveness analysis of using atorvastatin for secondary stroke prevention: a Spanish perspective
Mar, J.
Vivancos, J.
Rejas, J.
Arrospide, A.
Caro, J.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S695 - S695
[2] Analysis of yellow fever prevention strategy from the perspective of mathematical model and cost-effectiveness analysis
Handari, Bevina D.
Aldila, Dipo
Dewi, Bunga O.
Rosuliyana, Hanna
Khosnaw, Sarbaz H. A.
MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2022, 19 (02) : 1786 - 1824
[3] Cost-effectiveness of Restrictive Strategy Versus Usual Care for Cholecystectomy in Patients With Gallstones and Abdominal Pain (SECURE-trial)
Latenstein, Carmen S. S.
Wennmacker, Sarah Z.
van Dijk, Aafke H.
Drenth, Joost P. H.
Westert, Gert P.
van Laarhoven, Cornelis J. H. M.
Boermeester, Marja A.
de Reuver, Philip R.
Dijkgraaf, Marcel G. W.
ANNALS OF SURGERY, 2022, 276 (02) : E93 - E101
[4] Cost-effectiveness of a nurse facilitated, cognitive behavioural self-management programme compared with usual care using a CBT Manual alone for patients with heart failure: secondary analysis of data from the SEMAPHFOR trial
Mejia, Aurelio
Richardson, Gerry
Pattenden, Jill
Cockayne, Sarah
Lewin, Robert
INTERNATIONAL JOURNAL OF NURSING STUDIES, 2014, 51 (09) : 1214 - 1220
[5] Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective
Benner, JS
Smith, TW
Klingman, D
Tierce, JC
Mullins, CD
Pethick, N
O'Donnell, JC
VALUE IN HEALTH, 2005, 8 (06) : 618 - 628
[6] Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial
Singh, Kavita
Crossan, Catriona
Laba, Tracey-Lea
Roy, Ambuj
Hayes, Alison
Salam, Abdul
Jan, Stephen
Lord, Joanne
Tandon, Nikhil
Rodgers, Anthony
Patel, Anushka
Thom, Simon
Prabhakaran, Dorairaj
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 262 : 71 - 78
[7] Cost-effectiveness analysis of case management for optimized antithrombotic treatment in German general practices compared to usual care – results from the PICANT trial
Lisa R. Ulrich
Juliana J. Petersen
Karola Mergenthal
Andrea Berghold
Gudrun Pregartner
Rolf Holle
Andrea Siebenhofer
Health Economics Review, 9
[8] Cost-effectiveness analysis of case management for optimized antithrombotic treatment in German general practices compared to usual care - results from the PICANT trial
Ulrich, Lisa R.
Petersen, Juliana J.
Mergenthal, Karola
Berghold, Andrea
Pregartner, Gudrun
Holle, Rolf
Siebenhofer, Andrea
HEALTH ECONOMICS REVIEW, 2019, 9 (1)
[9] Bayesian cost-effectiveness analysis from clinical trial data
O'Hagan, A
Stevens, JW
Montmartin, J
STATISTICS IN MEDICINE, 2001, 20 (05) : 733 - 753
[10] THE COST-EFFECTIVENESS OF STATINS FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE: OBSERVATIONAL STUDY USING DATA FROM ROUTINE ELECTRONIC MEDICAL RECORDS
Mujica-Mota, R. E.
Hughes, P.
VALUE IN HEALTH, 2017, 20 (05) : A259 - A260

← 1 2 3 4 5 →